FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Miriam Souroujon

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Revital Aricha; Sonia Berrih-Aknin; Tali Feferman; Sara Fuchs; Miriam C Souroujon
Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Miriam C Souroujon; Revital Aricha; Tali Feferman; Keren Mizrachi; Debby Reuveni; Sara Fuchs
Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Revital Aricha; Keren Mizrachi; Sara Fuchs; Miriam C Souroujon
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Miriam Souroujon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Revital Aricha; Sonia Berrih-Aknin; Tali Feferman; Sara Fuchs; Miriam C Souroujon
Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Annals of the New York Academy of Sciences 2012;1275():107-13.
2012: Miriam C Souroujon; Revital Aricha; Tali Feferman; Keren Mizrachi; Debby Reuveni; Sara Fuchs
Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 2012;1274():120-6.
2011: Revital Aricha; Keren Mizrachi; Sara Fuchs; Miriam C Souroujon
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Journal of autoimmunity 2011;36(2):135-41.
2011: Revital Aricha; Tali Feferman; Hamish S Scott; Miriam C Souroujon; Sonia Berrih-Aknin; Sara Fuchs
The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
Journal of autoimmunity 2011;36(1):16-24.
2010: Tamar Liron; Tal Nahari; Miriam C Souroujon; Drorit Neumann
Insertion of an NPVY sequence into the cytosolic domain of the erythropoietin receptor selectively affects erythropoietin-mediated signalling and function.
The Biochemical journal 2010;427(2):305-12.
2010: Keren Mizrachi; Revital Aricha; Tali Feferman; Neta Kela-Madar; Ilana Mandel; Tamar Paperna; Ariel Miller; Avraham Ben-Nun; Sonia Berrih-Aknin; Miriam C Souroujon; Sara Fuchs
Involvement of phosphodiesterases in autoimmune diseases.
Journal of neuroimmunology 2010;220(1-2):43-51.
2009: Ariel Miller; Miriam C Souroujon; Francesca Aloisi
Translational neuroimmunology: a joint meeting of the Israel Society of Neuroimmunology and the Italian Neuroimmunology Association. Conference review.
Journal of neuroimmunology 2009;216(1-2):4-7.
2009: Tali Feferman; Revital Aricha; Keren Mizrachi; Erez Geron; Ronen Alon; Miriam C Souroujon; Sara Fuchs
Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
Journal of neuroimmunology 2009;209(1-2):87-95.
2008: Hwa-Jung Yi; Chang-Suk Chae; Jae-Seon So; Socrates J Tzartos; Miriam C Souroujon; Sara Fuchs; Sin-Hyeog Im
Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
Molecular immunology 2008;46(1):192-201.
2008: Renuka T R Menon; Tali Feferman; Revital Aricha; Miriam C Souroujon; Sara Fuchs
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
Journal of neuroimmunology 2008;201-202():128-35.
2008: Revital Aricha; Tali Feferman; Sara Fuchs; Miriam C Souroujon
Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(4):2132-9.
2008: Sara Fuchs; Tali Feferman; Roberto Meidler; Raanan Margalit; Camille Sicsic; Ningshan Wang; Kai-Yun Zhu; Talma Brenner; Orgad Laub; Miriam C Souroujon
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
Journal of neuroimmunology 2008;194(1-2):89-96.
2008: Sara Fuchs; Tali Feferman; Roberto Meidler; Raanan Margalit; Camille Sicsic; Talma Brenner; Orgad Laub; Miriam C Souroujon
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
Annals of the New York Academy of Sciences 2008;1132():244-8.
2008: Sara Fuchs; Tali Feferman; Roberto Meidler; Talma Brenner; Orgad Laub; Miriam C Souroujon
The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
The Israel Medical Association journal : IMAJ 2008;10(1):58-60.
2007: Sara Fuchs; Tali Feferman; Kai-Yun Zhu; Roberto Meidler; Raanan Margalit; Ningshan Wang; Orgad Laub; Miriam C Souroujon
Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
Annals of the New York Academy of Sciences 2007;1110():550-8.
2007: Tali Feferman; Revital Aricha; Renuka Menon; Miriam C Souroujon; Sonia Berrih-Aknin; Sara Fuchs
DNA microarray in search of new drug targets for myasthenia gravis.
Annals of the New York Academy of Sciences 2007;1107():111-7.
2006: Kai-Yun Zhu; Tali Feferman; Prasanta Maiti; Miriam C Souroujon; Sara Fuchs
Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.
Journal of neuroimmunology 2006;176(1-2):187-97.
2006: Revital Aricha; Tali Feferman; Miriam C Souroujon; Sara Fuchs
Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(2):374-6.
2005: Sonia Berrih-Aknin; Sara Fuchs; Miriam C Souroujon
Vaccines against myasthenia gravis.
Expert opinion on biological therapy 2005;5(7):983-95.
2005: Tali Feferman; Prasanta Maiti; Sonia Berrih-Aknin; Jacky Bismuth; Jocelyne Bidault; Sara Fuchs; Miriam C Souroujon
Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(9):5324-31.
2004: Prasanta Maiti; Tali Feferman; Sin-Hyeog Im; Miriam C Souroujon; Sara Fuchs
Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment.
Journal of neuroimmunology 2004;152(1-2):112-20.
2004: Miriam C Souroujon; Lina Yao; Haibin Chen; Gerda Endemann; Hanita Khaner; Virginie Geeraert; Deborah Schechtman; Adrienne S Gordon; Ivan Diamond; Daria Mochly-Rosen
State-specific monoclonal antibodies identify an intermediate state in epsilon protein kinase C activation.
The Journal of biological chemistry 2004;279(17):17617-24.
2003: Miriam C Souroujon; Prasanta Maiti; Tali Feferman; Sin-Hyeog Im; Lily Raveh; Sara Fuchs
Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors.
Annals of the New York Academy of Sciences 2003;998():533-6.
2003: Tali Feferman; Sin-Hyeog Im; Sara Fuchs; Miriam C Souroujon
Epitope spreading to hidden cytoplasmic regions of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 2003;998():388-90.
2003: Tali Feferman; Sin-Hyeog Im; Sara Fuchs; Miriam C Souroujon
Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
Journal of neuroimmunology 2003;140(1-2):153-8.
2003: Prasanta Maiti; Sin-Hyeog Im; Miriam C Souroujon; Sara Fuchs
A monoclonal antibody specific for rat IL-18BP and its application in determining serum IL-18BP.
Immunology letters 2003;85(1):65-70.
2002: Sin-Hyeog Im; Dora Barchan; Tali Feferman; Lily Raveh; Miriam C Souroujon; Sara Fuchs
Protective molecular mimicry in experimental myasthenia gravis.
Journal of neuroimmunology 2002;126(1-2):99-106.
2002: Sin-Hyeog Im; Soo-Hyun Kim; Tania Azam; Natarajan Venkatesh; Charles A Dinarello; Sara Fuchs; Miriam C Souroujon
Rat interleukin-18 binding protein: cloning, expression, and characterization.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(3):321-8.
2001: Sin-Hyeog Im; Dora Barchan; Prasanta Maiti; Lily Raveh; Miriam C Souroujon; Sara Fuchs
Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(12):2140-8.
2001: Sin-Hyeog Im; Dora Barchan; Prasanta Maiti; Sara Fuchs; Miriam C Souroujon
Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(11):6893-8.
2000: Sin-Hyeog Im; Dora Barchan; Sara Fuchs; Miriam C Souroujon
Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis.
Journal of neuroimmunology 2000;111(1-2):161-8.
2000: Sin-Hyeog Im; Dora Barchan; Miriam C Souroujon; Sara Fuchs
Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3599-605.
1999: Sin-Hyeog Im; Dora Barchan; Sara Fuchs; Miriam C Souroujon
Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.
The Journal of clinical investigation 1999;104(12):1723-30.
1999: Dora Barchan; Miriam C Souroujon; Sin-Hyeog Im; C Antozzi; Sara Fuchs
Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(14):8086-91.
1998: Miriam C Souroujon; Daria Mochly-Rosen
Peptide modulators of protein-protein interactions in intracellular signaling.
Nature biotechnology 1998;16(10):919-24.
1998: Miriam C Souroujon; Dora Barchan; Sara Fuchs
Modulation of experimental autoimmune myasthenia gravis by recombinant fragments of the human acetylcholine receptor.
Annals of the New York Academy of Sciences 1998;841():572-5.
1998: Dora Barchan; O Asher; Socrates J Tzartos; Sara Fuchs; Miriam C Souroujon
Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
European journal of immunology 1998;28(2):616-24.
1995: Dora Barchan; Moshe Balass; Miriam C Souroujon; Ephraim Katchalski-Katzir; Sara Fuchs
Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(9):4264-9.
1994: O Asher; Sara Fuchs; Miriam C Souroujon
Acetylcholine receptor and myogenic factor gene expression in Torpedo embryonic development.
Neuroreport 1994;5(13):1581-4.
1993: O Asher; Wilfried Kues; Veit Witzemann; S J Tzartos; Sara Fuchs; Miriam C Souroujon
Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(11):6442-50.
1993: Miriam C Souroujon; S Carmon; Sara Fuchs
Regulation of experimental autoimmune myasthenia gravis by synthetic peptides of the acetylcholine receptor.
Annals of the New York Academy of Sciences 1993;681():332-4.
1992: Miriam C Souroujon; S Carmon; Sara Fuchs
Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides.
Immunology letters 1992;34(1):19-25.
1991: Miriam C Souroujon; S Carmon; A Safran; Sara Fuchs
Differences between embryonic and adult Torpedo acetylcholine receptor gamma subunit.
FEBS letters 1991;288(1-2):222-6.
1987: Miriam C Souroujon; Sara Fuchs
Antiidiotypic antibodies in the regulation of experimental autoimmune myasthenia gravis.
Annals of the New York Academy of Sciences 1987;505():676-82.
1987: Sara Fuchs; D Neumann; A Safran; Miriam C Souroujon; Dora Barchan; Mati Fridkin; J M Gershoni; R Mantegazza; S Pizzighella
Synthetic peptides and their antibodies in the analysis of the acetylcholine receptor.
Annals of the New York Academy of Sciences 1987;505():256-71.
1986: Miriam C Souroujon; D Neumann; S Pizzighella; Mati Fridkin; Sara Fuchs
Mapping of the cAMP-dependent phosphorylation sites on the acetylcholine receptor.
The EMBO journal 1986;5(3):543-6.
1986: Miriam C Souroujon; D Neumann; S Pizzighella; A Safran; Sara Fuchs
Localization of a highly immunogenic region on the acetylcholine receptor alpha-subunit.
Biochemical and biophysical research communications 1986;135(1):82-9.
1985: Miriam C Souroujon; S Pizzighella; Daria Mochly-Rosen; Sara Fuchs
Antigenic specificity of acetylcholine receptor in developing muscle. Studies with monoclonal antibodies.
Journal of neuroimmunology 1985;8(2-3):159-66.
1985: Miriam C Souroujon; Dora Barchan; Sara Fuchs
Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
Immunology letters 1985;9(6):331-6.
1983: S Pizzighella; A S Gordon; Miriam C Souroujon; Daria Mochly-Rosen; A Sharp; Sara Fuchs
An anti-acetylcholine receptor monoclonal antibody cross-reacts with phosvitin.
FEBS letters 1983;159(1-2):246-50.
1983: Miriam C Souroujon; Daria Mochly-Rosen; A S Gordon; S Fuchs
Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle.
Muscle & nerve 1983;6(4):303-11.
1981: S Fuchs; D Bartfeld; D Mochly-Rosen; Miriam C Souroujon; C Feingold
Acetylcholine receptor: molecular dissection and monoclonal antibodies in the study of experimental myasthenia.
Annals of the New York Academy of Sciences 1981;377():110-24.